Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2016
Home
2016
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 4C – quarterly
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Significant scientific appointment for cellmid advisory board chair
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
4th MK Symposium Results
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Record monthly sales for Advangen Japan
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
évolis Professional Launch
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Directors Interest Notice – Maria Halasz
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
MK antibody publication and patent in bone healing
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Midkine interviews with Pharmatelevision published
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
USA Distribution Partnership for Cellmid’s évolis®
Prev page
1
2
3
4
5
6
Next page
